Search filters

List of works by Katsumasa Kuroi

A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer

scientific article published on 01 August 2009

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

scientific article published on 12 February 2019

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study) ⬇️

scientific article published on July 26, 2012

A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer

scientific article

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer

scientific article published on 17 January 2020

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

scientific article published on June 2017

Alternation of estrogen receptor and progesterone receptor expression in primary breast cancer patients treated with neoadjuvant chemotherapy

scientific article published on 10 June 2010

An overview of the Japan Breast Cancer Research Group (JBCRG) activities

scientific article

Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature

scientific article published on 25 July 2008

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery.

scientific article published on 17 June 2011

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

scientific article published on 27 February 2019

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

scientific article published on 8 February 2017

Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population

scientific article published in July 2010

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy ⬇️

scientific article

Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast ⬇️

scientific article published on 02 March 2011

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG.

scientific article

Comparison of outcomes between women with de novo stage IV and relapsed breast cancer

scientific article published on January 2014

Current status of health outcome assessment of medical treatment in breast cancer

scientific article published on January 2007

Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer ⬇️

scientific article published on July 1, 2011

Economic evaluation of the prevention and treatment of breast cancer--present status and open issues

scientific article published on January 2007

Effect of low-dose Paclitaxel and docetaxel on endothelial progenitor cells

scientific article

Effect of mechanical closure of dead space on seroma formation after breast surgery

scientific article published on January 2006

Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial

scientific article published on 22 December 2016

Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer

scientific article published in January 2002

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

scientific article

Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients

scientific article published on 01 August 2015

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

scientific article published on 8 October 2013

Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer

scientific article published on 15 August 2015

Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2

scientific article published on January 2015

Evidence-based risk factors for seroma formation in breast surgery

scientific article

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

scientific article published on 17 November 2017

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

scientific article

Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report ⬇️

scientific article published on October 4, 2011

Genome-wide copy number analysis in primary breast cancer ⬇️

scientific article published on 08 February 2012

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

scientific article published on 20 October 2020

HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma

scientific article published on June 1, 2010

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial.

scientific article published on 14 February 2018

Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery ⬇️

scientific article published on August 30, 2012

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

scientific article published in January 2005

Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved

scientific article published on 26 January 2016

Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer

scientific article

Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition

scientific article published on 10 February 2011

Male breast cancer

scientific article

Metastasis of breast carcinoma to rectus abdominis muscle.

scientific article published in January 2003

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

scientific article published on 01 August 2009

Neurotoxicity of taxanes: symptoms and quality of life assessment

scientific article published on January 2004

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

scientific article published on 10 February 2015

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

scientific article published on 14 February 2020

Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial

scientific article published on 23 October 2020

Pathophysiology of seroma in breast cancer

scientific article

Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer

scientific article published on 07 February 2019

Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer

scientific article published on 9 April 2015

Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival

scientific article published on 19 September 2007

Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model

scientific article

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm

scientific article published on 07 September 2018

Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy

scientific article published on 31 July 2019

Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients

scientific article published on June 1, 2010

Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer

scientific article published on 27 July 2016

Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG.

scientific article published on 14 December 2013

Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications

scientific article published on 15 May 2015

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).

scientific article published on 17 December 2008

Protracted administration of weekly docetaxel in metastatic breast cancer.

scientific article published in September 2003

Quality of Japanese health care evaluated as hospital functions

scientific article published on January 2007

Quality of life of breast cancer patients and types of surgery for breast cancer--current status and unresolved issues

scientific article published on January 2007

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer ⬇️

scientific article published on July 7, 2011

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

scientific article published on 12 April 2014

Recent topics of health outcomes research in oncology

scientific article published on January 2007

Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

scientific article published on 31 March 2010

Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer ⬇️

scientific article published on August 19, 2011

Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)

scientific article published in October 2007

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer

scientific article

Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol

scientific article published on August 10, 2011

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational

scientific article published on 05 July 2018

Sustained complete response in lung metastasis of breast cancer by goserelin--report of two cases

scientific article published in April 2002

Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial ⬇️

scientific article published on May 15, 2012

Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management

scientific article published on 30 April 2019

Weekly schedule of docetaxel in breast cancer: evaluation of response and toxicity

scientific article

[A case of primary breast cancer responding to pre-operative chemotherapy with the combination of paclitaxel and carboplatin for ovarian cancer]

scientific article published on 01 June 2012

[Anti-Her2 therapy in breast cancer].

scientific article

[Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]

scientific article published on 01 September 2012

[Predictors of axillary node metastasis at breast surgery after neoadjuvant chemotherapy in patients with pre- chemotherapy-sentinel node positive breast cancer]

scientific article published on 01 October 2011

[The significance for prognostic factor of pathological complete response (pCR) after neoadjuvant chemotherapy].

scientific article

[Toxicity of Palbociclib in Patients Aged 70 Years and Older with Metastatic Breast Cancer]

scientific article published on 01 July 2019

Paulina is supported by:

About Paulina

Help